The Quantellect read.As of Nov 19, 2026, 11 active firms cover Axogen Inc: 11 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $36.00 to $55.00, a moderate spread. The average target of $49.55 sits 13% below the current $56.94. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 9 to 11 over recent months. On the fundamentals, the Street sees revenue growth near 20% this year and 18% next, consensus EPS building from about $0.13 next quarter toward $0.71 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 active firms
Buy
Strong Buy00%
Buy11100%
Neutral00%
Sell00%
Strong Sell00%
Based on 11 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$49.55
-13.0% downside
Average target across 11 active firms as of Nov 19, 2026 vs $56.94 current
Highest Target$55.00
Average Target$49.55
Lowest Target$36.00
Detailed analyst forecasts for AXGN
Showing 1–12 of 12 named analysts shown · 11 active firms in the rating projection
As of Nov 19, 2026, 11 of 11 active firms rate AXGN a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
AXGN EPS & revenue forecast
EPS · NEXT QUARTER
$0.13
Range $0.07 – $0.18 · 8 analysts · +81% YoY
Next period, 8 analysts expect Axogen Inc to earn $0.13 a share (range $0.07 – $0.18), versus $0.07 a year earlier. Full-year consensus is $0.55, growing to $0.71 the year after.
REVENUE · NEXT QUARTER
$80.6M
Range $77.7M – $86.4M · 8 analysts · +18% YoY
Revenue is expected to reach $80.6M (range $77.7M – $86.4M), +18.0% year-over-year. Full-year consensus is $290.4M, rising to $372.7M next year.
Top analysts covering Axogen Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AXGN.
#1
Anthony Petrone
Mizuho · Rank #121
Buy
$58.00+1.9% to target
Overall win rate
45%
+ Follow
#2
JB
Jayson Bedford
Raymond James · Rank #191
Buy
$53.00-6.9% to target
Overall win rate
44%
+ Follow
#3
Ross Osborn
Cantor Fitzgerald · Rank #238
Buy
$26.00-54.3% to target
Overall win rate
34%
+ Follow
#4
CC
Caitlin Cronin
Canaccord Genuity · Rank #260
Buy
$40.00-29.8% to target
Overall win rate
39%
+ Follow
#5
Yi Chen
HC Wainwright & Co. · Rank #350
Buy
$56.00-1.7% to target
Overall win rate
34%
+ Follow
AXGN stock forecast FAQ
What is AXGN's average 12-month price target?+
The 11 active firms with a live target average $49.55 for Axogen Inc over the next 12 months, ranging from a $55.00 high to a $36.00 low, as of Nov 19, 2026.
Is AXGN stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 11 active firms as of Nov 19, 2026, 11 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for AXGN?+
The Street-high target is $55.00 (Canaccord Genuity), and the Street-low is $36.00 (Jefferies). The average of all 11 active-firm targets is $49.55.
How many active Wall Street firms cover AXGN?+
11 active firms have a recognized rating on Axogen Inc as of Nov 19, 2026, and 11 active firms carry a live 12-month price target.
Who is the most accurate analyst covering AXGN?+
Among analysts who currently cover AXGN, Anthony Petrone of Mizuho has the strongest overall Quantellect track record (Rank #121). Their current call is Buy with a $58.00 target.
What is Axogen Inc's projected EPS for next quarter?+
The consensus estimate is $0.13 per share (range $0.07 – $0.18) across 8 analysts. Full-year EPS is projected at $0.55, rising to $0.71 the following year.
How much revenue is Axogen Inc expected to report next quarter?+
Consensus revenue is $80.6M (range $77.7M – $86.4M). Full-year revenue is projected at $290.4M, growing to $372.7M next year.
Have analysts been upgrading or downgrading AXGN lately?+
As of Nov 19, 2026, 11 of 11 active firms rate AXGN a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AXGN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.